You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

VITAMIN K1 Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Vitamin K1 patents expire, and when can generic versions of Vitamin K1 launch?

Vitamin K1 is a drug marketed by Hospira and is included in three NDAs.

The generic ingredient in VITAMIN K1 is phytonadione. There are ten drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the phytonadione profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Vitamin K1

A generic version of VITAMIN K1 was approved as phytonadione by AMNEAL PHARMS CO on May 11th, 2018.

  Subscribe

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VITAMIN K1?
  • What are the global sales for VITAMIN K1?
  • What is Average Wholesale Price for VITAMIN K1?
Drug patent expirations by year for VITAMIN K1

US Patents and Regulatory Information for VITAMIN K1

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Hospira VITAMIN K1 phytonadione INJECTABLE;INJECTION 087954-001 Jul 25, 1983 BP RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hospira VITAMIN K1 phytonadione INJECTABLE;INJECTION 087955-001 Jul 25, 1983 AB1 RX Yes Yes ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Hospira VITAMIN K1 phytonadione INJECTABLE;INJECTION 087956-001 Jul 25, 1983 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

VITAMIN K1 Market Analysis and Financial Projection Experimental

Vitamin K1 Market Dynamics and Financial Trajectory

Introduction to Vitamin K1

Vitamin K1, also known as phylloquinone, is a fat-soluble vitamin that plays a crucial role in blood clotting, bone health, and cardiovascular well-being. It is predominantly found in leafy green vegetables and certain animal products. The market for Vitamin K1 is experiencing significant growth, driven by various factors.

Market Size and Projections

The Vitamin K1 market was valued at USD 3.1 billion in 2023 and is projected to reach USD 5.2 billion by 2031, growing at a Compound Annual Growth Rate (CAGR) of 6.8% from 2024 to 2031[1].

Market Segmentation

The Vitamin K1 market is segmented based on several key factors:

Application

The market is categorized by various applications, including the transportation industry and underground mining, although these are less relevant to the health and nutritional sectors. The primary focus remains on health-related applications such as osteoporosis, vitamin K-dependent clotting factor deficiency (VKCFD), and other medical conditions[1][4].

Product

The market is also segmented by product type, with Vitamin K1 being one of the main forms of vitamin K. This includes dietary supplements, pharmaceutical formulations, and fortified foods[4].

Geographical Regions

The market is analyzed across different geographical regions, including North America, Europe, Asia-Pacific, South America, and the Middle-East and Africa. North America holds a significant market share due to the presence of prominent manufacturers, an increasing geriatric population, and rising awareness of nutritional benefits[1][4].

Drivers of Market Growth

Several factors are driving the growth of the Vitamin K1 market:

Increasing Health Consciousness

There is a growing health consciousness among consumers, leading to an increased demand for dietary supplements that support long-term well-being. This trend is particularly evident among aging populations who are at higher risk for osteoporosis and cardiovascular diseases[3][4].

Rising Health Expenditure

Higher disposable incomes and increased health expenditure globally are enabling consumers to invest more in premium health products, including Vitamin K1 supplements[3].

Scientific Research and Awareness

Continued scientific research highlighting the benefits of Vitamin K1, such as its role in preventing fractures, reducing cancer incidence, and improving bone strength, is increasing awareness and demand for this vitamin[2][4].

Restraints and Challenges

Despite the growth, there are several restraints and challenges facing the Vitamin K1 market:

Regulatory Frameworks

Stringent regulatory frameworks in different regions can pose challenges to the market growth. Compliance with various regulations can be complex and costly for manufacturers[4].

Competition from Alternative Products

The presence of alternative health products and supplements can compete with Vitamin K1 for market share. Consumers may opt for other vitamins or supplements that offer similar health benefits[4].

Cost and Accessibility

The cost of Vitamin K1 supplements and pharmaceuticals can be a barrier for some consumers, especially in regions with lower disposable incomes. Accessibility to these products can also be limited in certain areas[4].

Financial Trajectory

The financial trajectory of the Vitamin K1 market is promising:

  • Current Market Value: The market was valued at USD 3.1 billion in 2023[1].
  • Projected Market Value: It is expected to reach USD 5.2 billion by 2031[1].
  • CAGR: The market is growing at a CAGR of 6.8% from 2024 to 2031[1].

Regional Financial Outlook

  • North America: This region holds a significant market share and is expected to continue growing due to the presence of prominent manufacturers and increasing health awareness[4].
  • Asia-Pacific: This region is expected to grow at the fastest rate due to increasing health concerns, rising demand for nutritional products, and the need for vitamin K1 injectables to prevent infant complications[4].

Health Benefits and Market Impact

The health benefits of Vitamin K1 are a key driver of market growth:

Bone Health

Vitamin K1 has been shown to reduce clinical fractures in postmenopausal women with osteopenia and improve bone strength without necessarily increasing bone mineral density[2].

Cancer Prevention

There is evidence that Vitamin K1 can reduce the incidence of cancer, particularly liver cancer, in certain patient groups[2].

Cardiovascular Health

Vitamin K1 helps in preventing vascular calcifications and reducing the progression of arterial calcification, which is beneficial for cardiovascular health[2].

Consumer Behavior and Market Trends

Consumer behavior is significantly influencing the Vitamin K1 market:

  • Holistic Health and Wellness: Consumers are increasingly focusing on holistic health and wellness, leading to a higher demand for products that offer specific health benefits like Vitamin K1[3].
  • Dietary Supplements: The demand for dietary supplements is rising, with consumers seeking out products that can support their long-term health and well-being[3].

Key Players and Competitive Landscape

The Vitamin K1 market is competitive, with several key players involved in the production and distribution of Vitamin K1 products. These players are investing in research and development to innovate and expand their product offerings, which is further driving market growth[4].

Conclusion

The Vitamin K1 market is poised for significant growth driven by increasing health consciousness, rising health expenditure, and the growing awareness of the health benefits of Vitamin K1. Despite some restraints and challenges, the financial trajectory of the market is promising, with a projected value of USD 5.2 billion by 2031.

Key Takeaways

  • The Vitamin K1 market is valued at USD 3.1 billion in 2023 and is expected to reach USD 5.2 billion by 2031.
  • The market is growing at a CAGR of 6.8% from 2024 to 2031.
  • Increasing health consciousness and rising health expenditure are key drivers of market growth.
  • The market is segmented by application, product type, and geographical regions.
  • North America holds a significant market share, while the Asia-Pacific region is expected to grow at the fastest rate.

FAQs

  1. What are the primary health benefits of Vitamin K1? Vitamin K1 is beneficial for bone health, reducing clinical fractures and improving bone strength. It also has anticancer properties and helps in preventing vascular calcifications[2].

  2. What is the projected market value of Vitamin K1 by 2031? The Vitamin K1 market is expected to reach USD 5.2 billion by 2031[1].

  3. Which region is expected to grow the fastest in the Vitamin K1 market? The Asia-Pacific region is expected to grow at the fastest rate due to increasing health concerns and rising demand for nutritional products[4].

  4. What are the main drivers of the Vitamin K1 market growth? The main drivers include increasing health consciousness, rising health expenditure, and growing awareness of the health benefits of Vitamin K1[3][4].

  5. What are some of the restraints facing the Vitamin K1 market? Stringent regulatory frameworks, competition from alternative products, and cost and accessibility issues are some of the restraints facing the market[4].

Sources

  1. Market Research Intellect: Vitamin K1 Market Size and Projections.
  2. Open Heart: The health benefits of vitamin K.
  3. MarketsandMarkets: Vitamin K2 Market Trends, Share, Opportunities, and Revenue.
  4. Precedence Research: Vitamin K Market Size, Share, and Trends 2024 to 2033.

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.